S2295 EUS-Gallbladder Drainage-Assisted Assessment of Microbial Profile in Patients With Cholecystitis: A Multicentered Experience

Introduction: Endoscopic Ultrasound gallbladder drainage (EUS-GBD) is now used for the management of patients with cholecystitis who are not appropriate surgical candidates. In practice, empiric, broad-spectrum antibiotics are used in the treatment of cholecystitis; however, this is based on data from several decades ago. Methods: We aimed to generate an updated microbial from sampled fluid within the gallbladder in non-surgical patients with cholecystitis undergoing EUS-GBD. Retrospective analysis was conducted from prospectively collected data. Results: Sixty-one patients underwent EUS-GBD at our 5-hospital system. Of these, 45 patients (73.8%) underwent fine needle aspiration of gallbladder contents, and subsequent cultures were performed on aspirated fluid. After microbiology review, reliable cultures were confirmed in 25 patients (55.6%). Isolated bacteria included: Escherichia coli (26.7%; 1 patient with extended spectrum beta-lactamase variant), Enterococcus faecalis (22.2%; 3 with vancomycin-resistance), Streptococcal species (15.6%), Klebsiella pneumoniae (11.1%; one with multi-drug resistance), Pseudomonas aeruginosa (11.1%), Enterobacter cloacae (4.4%), Methicillin-Resistant Staphylococcus aureus (4.4%), Serratia marcescens (2.2%). Isolated fungal species included: Candida albicans (17.8%), Candida glabrata (4.4%), and Candida tropicalis (2.2%). There was no difference in clinical outcomes in patients with reliable culture results as compared to those found to have contaminant (20 patients, 44.4%); compared to those with no growth on culture (3 patients, 6.7%); nor compared to those who did not have cultures obtained (16 patients). There was no difference in likelihood of a reliable culture with transantral versus transduodenal sampling (P = 0.7). There was no recurrence of cholecystitis in any patient who underwent EUS-GBD. Conclusion: Updated culture data from intact gallbladders in the setting of active cholecystitis is now available based on this study and differ, somewhat to previously published data.

Authors

Publication Details

Journal
The American Journal of Gastroenterology
Published
2025-10-01
DOI
https://doi.org/10.14309/01.ajg.0001136640.62269.84
Primary Topic
Gallbladder and Bile Duct Disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

S2295 EUS-Gallbladder Drainage-Assisted Assessment of Microbial Profile in Patients With Cholecystitis: A Multicentered Experience

Edward Villa, Mitchelle Zolotarvesky
The American Journal of Gastroenterology
Gallbladder and Bile Duct Disorders
article

S2295 EUS-Gallbladder Drainage-Assisted Assessment of Microbial Profile in Patients With Cholecystitis: A Multicentered Experience

Edward Villa, Mitchelle Zolotarvesky
article en

Abstract

Introduction: Endoscopic Ultrasound gallbladder drainage (EUS-GBD) is now used for the management of patients with cholecystitis who are not appropriate surgical candidates. In practice, empiric, broad-spectrum antibiotics are used in the treatment of cholecystitis; however, this is based on data from several decades ago. Methods: We aimed to generate an updated microbial from sampled fluid within the gallbladder in non-surgical patients with cholecystitis undergoing EUS-GBD. Retrospective analysis was conducted from prospectively collected data. Results: Sixty-one patients underwent EUS-GBD at our 5-hospital system. Of these, 45 patients (73.8%) underwent fine needle aspiration of gallbladder contents, and subsequent cultures were performed on aspirated fluid. After microbiology review, reliable cultures were confirmed in 25 patients (55.6%). Isolated bacteria included: Escherichia coli (26.7%; 1 patient with extended spectrum beta-lactamase variant), Enterococcus faecalis (22.2%; 3 with vancomycin-resistance), Streptococcal species (15.6%), Klebsiella pneumoniae (11.1%; one with multi-drug resistance), Pseudomonas aeruginosa (11.1%), Enterobacter cloacae (4.4%), Methicillin-Resistant Staphylococcus aureus (4.4%), Serratia marcescens (2.2%). Isolated fungal species included: Candida albicans (17.8%), Candida glabrata (4.4%), and Candida tropicalis (2.2%). There was no difference in clinical outcomes in patients with reliable culture results as compared to those found to have contaminant (20 patients, 44.4%); compared to those with no growth on culture (3 patients, 6.7%); nor compared to those who did not have cultures obtained (16 patients). There was no difference in likelihood of a reliable culture with transantral versus transduodenal sampling (P = 0.7). There was no recurrence of cholecystitis in any patient who underwent EUS-GBD. Conclusion: Updated culture data from intact gallbladders in the setting of active cholecystitis is now available based on this study and differ, somewhat to previously published data.

The American Journal of GastroenterologyVol. 120(10S2)
Openalex Percentile: Top 42%
Gallbladder and Bile Duct Disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.